BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 20551754)

  • 21. Neoadjuvant chemoradiation increases the risk of pelvic sepsis after radical excision of rectal cancer.
    Buie WD; MacLean AR; Attard JA; Brasher PM; Chan AK
    Dis Colon Rectum; 2005 Oct; 48(10):1868-74. PubMed ID: 16175323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status.
    Read TE; Andujar JE; Caushaj PF; Johnston DR; Dietz DW; Myerson RJ; Fleshman JW; Birnbaum EH; Mutch MG; Kodner IJ
    Dis Colon Rectum; 2004 Jun; 47(6):825-31. PubMed ID: 15108025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI after chemoradiotherapy of rectal cancer: a useful tool to select patients for local excision.
    Engelen SM; Beets-Tan RG; Lahaye MJ; Lammering G; Jansen RL; van Dam RM; Konsten J; Leijtens JW; van de Velde CJ; Beets GL
    Dis Colon Rectum; 2010 Jul; 53(7):979-86. PubMed ID: 20551748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Injecting methylene blue into the inferior mesenteric artery assures an adequate lymph node harvest and eliminates pathologist variability in nodal staging for rectal cancer.
    Kerwel TG; Spatz J; Anthuber M; Wünsch K; Arnholdt H; Märkl B
    Dis Colon Rectum; 2009 May; 52(5):935-41. PubMed ID: 19502859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response.
    Murphy J; Pocard M; Jass JR; O'Sullivan GC; Lee G; Talbot IC
    Dis Colon Rectum; 2007 Oct; 50(10):1526-34. PubMed ID: 17828403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy?
    Kiran RP; Kirat HT; Burgess AN; Nisar PJ; Kalady MF; Lavery IC
    Ann Surg Oncol; 2012 Apr; 19(4):1206-12. PubMed ID: 21935748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.
    Tsikitis VL; Larson DL; Wolff BG; Kennedy G; Diehl N; Qin R; Dozois EJ; Cima RR
    J Am Coll Surg; 2009 Jan; 208(1):42-7. PubMed ID: 19228501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant therapy for rectal cancer down-stages the tumor but reduces lymph node harvest significantly.
    Wijesuriya RE; Deen KI; Hewavisenthi J; Balawardana J; Perera M
    Surg Today; 2005; 35(6):442-5. PubMed ID: 15912290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node retrieval in rectal cancer is dependent on many factors--the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist.
    Mekenkamp LJ; van Krieken JH; Marijnen CA; van de Velde CJ; Nagtegaal ID;
    Am J Surg Pathol; 2009 Oct; 33(10):1547-53. PubMed ID: 19661781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye?
    Mignanelli ED; de Campos-Lobato LF; Stocchi L; Lavery IC; Dietz DW
    Dis Colon Rectum; 2010 Mar; 53(3):251-6. PubMed ID: 20173469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Location of rectal cancer within the circumference of the rectum does not influence lymph node status.
    Ulrich A; Himmer K; Koch M; Kienle P; Büchler MW; Weitz J
    Ann Surg Oncol; 2007 Aug; 14(8):2257-62. PubMed ID: 17520316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancer.
    Caricato M; Ausania F; De Dominicis E; Vincenzi B; Rabitti C; Tonini G; Cellini F; Coppola R
    Eur J Surg Oncol; 2007 Aug; 33(6):724-8. PubMed ID: 17336482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Influence of Neoadjuvant Treatment on the Number of Lymph Nodes on the Surgical Specimen in Mid and Low Rectal Cancer - A Retrospective Single-Centre Study.
    Scripcariu DV; Moraru GV; Huţanu I; Filip B; Gavrilescu MM; Muşină AM; Buna-Arvinte M; Aniţei MG; Ferariu D; Moscalu M; Scripcariu V
    Chirurgia (Bucur); 2019; 114(2):207-215. PubMed ID: 31060653
    [No Abstract]   [Full Text] [Related]  

  • 38. Neoadjuvant therapy for rectal cancer decreases the number of lymph nodes harvested in operative specimens.
    Amajoyi R; Lee Y; Recio PJ; Kondylis PD
    Am J Surg; 2013 Mar; 205(3):289-92; discussion 292. PubMed ID: 23351510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Squamous-cell carcinoma of the rectum: a rare but curable tumor.
    Nahas CS; Shia J; Joseph R; Schrag D; Minsky BD; Weiser MR; Guillem JG; Paty PB; Klimstra DS; Tang LH; Wong WD; Temple LK
    Dis Colon Rectum; 2007 Sep; 50(9):1393-400. PubMed ID: 17661147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision.
    Kim YW; Kim NK; Min BS; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2009 Jun; 249(6):965-72. PubMed ID: 19474683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.